Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-delta,gamma Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab Casulo, C., Sancho, J., Van Eygen, K., de Vos, S., Mercadal, S., Johnson, R. J., Bouabdallah, K., Holmes, H., Lemmens, J., Gyan, E., Merli, M., Advani, R. H., Steelman, L., Pearlberg, J., Goy, A. AMER SOC HEMATOLOGY. 2016
View details for Web of Science ID 000394452307154